Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

NCT06740383 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT06740383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06740383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
June 30, 2027
Enrollment
320 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar 1 disorder, delusional disorder, early psychosis, psychosis not otherwise specified, schizoaffective disorder, schizophrenia, schizophrenia spectrum and other psychotic disorders